Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus
about
Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacyContribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosisStudies on the antimicrobial properties of N-acylated ciprofloxacins.Looking to nature for a new concept in antimicrobial treatments: isoflavonoids from Cytisus striatus as antibiotic adjuvants against MRSA.Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus.Deoxynybomycins inhibit mutant DNA gyrase and rescue mice infected with fluoroquinolone-resistant bacteriaImpact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus.Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.Contribution of phenotypic heterogeneity to adaptive antibiotic resistance.Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus.Alternatives to conventional antimicrobial drugs: a review of future prospects.Multidrug Efflux Pumps in Staphylococcus aureus: an Update.Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Diversity of Multidrug Efflux Genes and Phenotypic Evaluation of the In vitro Resistance Dynamics of Clinical Staphylococcus Aureus Isolates Using Methicillin; a Model β-lactam.Efflux drug transporters at the forefront of antimicrobial resistance.Multidrug efflux pumps in Staphylococcus aureus and their clinical implications.Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria.Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from BrazilResistance to Antimicrobials Mediated by Efflux Pumps in Staphylococcus aureus.Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps.Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections.Correction: Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus.Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.Resistance in In Vitro Selected Tigecycline-Resistant Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Is Driven by Mutations in mepR and mepA Genes.Efflux Pumps Might Not Be the Major Drivers of QAC Resistance in Methicillin-Resistant Staphylococcus aureus.
P2860
Q26824268-179D5617-711E-413A-A6A9-1FF525D17E59Q28482174-2E32B30D-DDBD-419C-896C-81C86D1F5A82Q31096940-39B8BC1E-A951-43CA-9FF9-0B25782DA486Q33812794-D8ADF54F-531D-43F6-8474-D933A127BB64Q34316945-7D4607CF-3E06-40E8-8B94-67305FE51975Q35574888-D161610D-2220-4771-BB26-A9A886801E10Q35820445-8F844176-02F4-4B02-82E2-2D8496E335C0Q36090275-65CC4B24-016F-4A58-AC2F-2BCBECBED8C0Q37286906-279A501A-E250-4525-8171-B079003557A9Q37475114-E5321988-9212-41FA-9094-4DF22E541E1EQ37490975-38E86BED-1BCB-481B-B4E5-04DC534C158AQ37697676-A6949DD6-0300-40A9-9EB5-2A4F1AA3D441Q37992684-139F3C14-B4D2-4EBA-9644-9361C1B8D8E9Q38097430-9ACF102E-9B51-4496-A436-AE2583F5290DQ38166534-68F47DDE-1E70-4BFF-BD18-B6804D39D27EQ38233471-924DDE82-F652-4344-9663-0F1B9AE2E168Q38609253-0E67F209-1EC4-4B07-B3CF-D65029F9CEDFQ38657292-106EA4B8-3316-4AC4-8B7A-1F596285A64AQ38686020-04CF42B3-ABB3-44A8-AE9D-AF307815B0D6Q38793887-44621FAE-8EC2-4A62-BDEC-7BC0CD9BC882Q38949658-0AE12A6B-42DE-438B-8E84-4A323D33A00EQ38954275-EE36EA95-DF0C-46E4-8145-6604A9E80FC7Q41848835-110FDC5E-5B82-4921-AE06-E13A5E076C78Q42229272-EC1F2A63-CB68-4BD1-87C3-25EAA349AEEFQ46506425-4AE3635E-4344-4D13-A532-C54F1756C07CQ46771227-652D629B-F025-4196-92B5-3FC5EBF87A7EQ50067895-7616DBC2-92A0-4C0D-86C2-E8A70F1CCCD4Q50079090-1D36E9A0-435E-4348-A116-9BFF1196BB78Q50998268-2B05E191-2E81-46E3-A8D7-47CB29B7C16D
P2860
Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exploring the contribution of ...... lates of Staphylococcus aureus
@ast
Exploring the contribution of ...... lates of Staphylococcus aureus
@en
Exploring the contribution of ...... lates of Staphylococcus aureus
@nl
type
label
Exploring the contribution of ...... lates of Staphylococcus aureus
@ast
Exploring the contribution of ...... lates of Staphylococcus aureus
@en
Exploring the contribution of ...... lates of Staphylococcus aureus
@nl
prefLabel
Exploring the contribution of ...... lates of Staphylococcus aureus
@ast
Exploring the contribution of ...... lates of Staphylococcus aureus
@en
Exploring the contribution of ...... lates of Staphylococcus aureus
@nl
P2860
P50
P356
P1433
P1476
Exploring the contribution of ...... lates of Staphylococcus aureus
@en
P2093
Celeste Falcão
P2860
P2888
P356
10.1186/1471-2180-11-241
P50
P577
2011-10-27T00:00:00Z
P5875
P6179
1030293721